Literature DB >> 17368527

Serotonin receptor involvement in effects of restraint on female rat lordosis behavior.

Lynda Uphouse1, Cindy Hiegel, Erika Perez, Jutatip Guptarak.   

Abstract

Ovariectomized Fischer (CDF-344) rats, with bilateral cannulae in the mediobasal hypothalamus (MBH) near the ventromedial nucleus of the hypothalamus (VMN), were used to test the hypothesis that serotonin receptors in the VMN contribute to the lordosis-inhibiting effects of mild restraint. Rats were hormonally primed with 10 microg estradiol benzoate (EB) followed 48 h later with sesame seed oil. Four to six hours later (during the dark portion of the light-dark cycle), rats were pretested for sexual behavior. Thereafter, they were infused with saline, 2 microg of the serotonin (5-HT) 2 receptor agonist, (+/-)-2,5-dimethoxy-4-iodophenyl-2-aminopropane HCl (DOI), or 1 microg of the 5-HT(1A) receptor antagonist, N-{2[4-(2-methoxyphenyl)-1-piperazinyl]ethyl}-N-(2-pyridinyl) cyclohexanecarboxamide trihydrochloride (WAY100635). After a 5 min restraint, rats were tested for sexual receptivity. Rats infused with saline showed a significant decline in lordosis behavior after restraint. Infusion with either DOI or WAY100635 attenuated these effects of restraint. These findings extend earlier observations that the lordosis-disruptive effects of mild restraint include activation of 5-HT(1A) receptors in the VMN and are the first to implicate VMN 5-HT(2) receptors in protection against mild restraint.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17368527      PMCID: PMC2043475          DOI: 10.1016/j.pbb.2007.02.007

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  38 in total

1.  Estrous cycle modulation of extracellular serotonin in mediobasal hypothalamus: role of the serotonin transporter and terminal autoreceptors.

Authors:  S Maswood; W Truitt; M Hotema; M Caldarola-Pastuszka; L Uphouse
Journal:  Brain Res       Date:  1999-06-12       Impact factor: 3.252

Review 2.  A conceptual model of the influence of stress on female reproduction.

Authors:  Hilary Dobson; Sarvpreet Ghuman; Sushil Prabhakar; Robert Smith
Journal:  Reproduction       Date:  2003-02       Impact factor: 3.906

3.  Gonadal hormones modulate 5-hydroxytryptamine2A receptors: emphasis on the rat frontal cortex.

Authors:  M Cyr; R Bossé; T Di Paolo
Journal:  Neuroscience       Date:  1998-04       Impact factor: 3.590

4.  Estrogen increases the density of 5-hydroxytryptamine(2A) receptors in cerebral cortex and nucleus accumbens in the female rat.

Authors:  B E Summer; G Fink
Journal:  J Steroid Biochem Mol Biol       Date:  1995-07       Impact factor: 4.292

5.  Estrogen desensitizes 5-HT(1A) receptors and reduces levels of G(z), G(i1) and G(i3) proteins in the hypothalamus.

Authors:  D K Raap; L DonCarlos; F Garcia; N A Muma; W A Wolf; G Battaglia; L D Van de Kar
Journal:  Neuropharmacology       Date:  2000-07-24       Impact factor: 5.250

6.  The PKC inhibitor, bisindolymaleimide, blocks DOI's attenuation of the effects of 8-OH-DPAT on female rat lordosis behavior.

Authors:  Amutha Selvamani; Christi Lincoln; Lynda Uphouse
Journal:  Behav Brain Res       Date:  2007-01-31       Impact factor: 3.332

7.  Effect of estrogen on the lordosis-inhibiting action of ketanserin and SB 206553.

Authors:  L Sinclair-Worley; L Uphouse
Journal:  Behav Brain Res       Date:  2004-06-04       Impact factor: 3.332

8.  Protein kinase C induces phosphorylation and desensitization of the human 5-HT1A receptor.

Authors:  J R Raymond
Journal:  J Biol Chem       Date:  1991-08-05       Impact factor: 5.157

9.  Intracerebral actions of the 5-HT1A agonists, 8-OH-DPAT and buspirone and of the 5-HT1A partial agonist/antagonist, NAN-190, on female sexual behavior.

Authors:  L Uphouse; M Caldarola-Pastuszka; S Montanez
Journal:  Neuropharmacology       Date:  1992-10       Impact factor: 5.250

10.  Protective actions of the 5-HT2A/2C receptor agonist, DOI, on 5-HT1A receptor-mediated inhibition of lordosis behavior.

Authors:  S Maswood; M Andrade; M Caldarola-Pastuszka; L Uphouse
Journal:  Neuropharmacology       Date:  1996-04       Impact factor: 5.250

View more
  9 in total

1.  Mechanisms responsible for progesterone's protection against lordosis-inhibiting effects of restraint I. Role of progesterone receptors.

Authors:  James Hassell; Chandra Suma Johnson Miryala; Cindy Hiegel; Lynda Uphouse
Journal:  Horm Behav       Date:  2011-05-20       Impact factor: 3.587

2.  Prior hormonal treatment, but not sexual experience, reduces the negative effects of restraint on female sexual behavior.

Authors:  Lynda Uphouse; Cindy Hiegel; Sarah Adams; Vanessa Murillo; Monique Martinez
Journal:  Behav Brain Res       Date:  2013-10-27       Impact factor: 3.332

3.  Tropisetron increases the inhibitory effect of mild restraint on lordosis behavior of hormonally primed, ovariectomized rats.

Authors:  Lynda Uphouse; Danyeal Heckard; Cindy Hiegel; Jutatip Guptarak; Sharmin Maswood
Journal:  Behav Brain Res       Date:  2011-01-14       Impact factor: 3.332

4.  Progesterone reduces the inhibitory effect of a serotonin 1B receptor agonist on lordosis behavior.

Authors:  Lynda Uphouse; Jutatip Guptarak; Cindy Hiegel
Journal:  Pharmacol Biochem Behav       Date:  2010-09-09       Impact factor: 3.533

5.  Mechanisms responsible for progesterone's protection against lordosis-inhibiting effects of restraint II. Role of progesterone metabolites.

Authors:  Chandra Suma Johnson Miryala; James Hassell; Sarah Adams; Cindy Hiegel; Ndidi Uzor; Lynda Uphouse
Journal:  Horm Behav       Date:  2011-05-20       Impact factor: 3.587

Review 6.  Conceptualizing the role of estrogens and serotonin in the development and maintenance of bulimia nervosa.

Authors:  Tom Hildebrandt; Lauren Alfano; Michelle Tricamo; Donald W Pfaff
Journal:  Clin Psychol Rev       Date:  2010-05-31

7.  Repeated estradiol benzoate treatment protects against the lordosis-inhibitory effects of restraint and prevents effects of the antiprogestin, RU486.

Authors:  Lynda Uphouse; Cindy Hiegel; Giovanny Martinez; Christian Solano; William Gusick
Journal:  Pharmacol Biochem Behav       Date:  2015-07-17       Impact factor: 3.533

8.  Progesterone reduces the effect of the serotonin 1B/1D receptor antagonist, GR 127935, on lordosis behavior.

Authors:  Lynda Uphouse; Cindy Hiegel; Jutatip Guptarak; Navin Maswood
Journal:  Horm Behav       Date:  2008-10-08       Impact factor: 3.587

9.  RU486 blocks effects of allopregnanolone on the response to restraint stress.

Authors:  Lynda Uphouse; Sarah Adams; Chandra Suma Johnson Miryala; James Hassell; Cindy Hiegel
Journal:  Pharmacol Biochem Behav       Date:  2012-10-06       Impact factor: 3.533

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.